Solvonis Therapeutics plc (LON:SVNS)

Revenue by Product

Financials in millions GBX. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2018	Dec 31, 2017
Polymer	587.00K
Polymer Growth	28.73%

Revenue by Geography

Financials in millions GBX. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2018	Dec 31, 2017
Europe	355.00K
Europe Growth	-14.46%
Slovenia	166.00K
Slovenia Growth	30.71%
Rest of the World	66.00K